2m 2m 2m 2m 2m 2m 2m
ELEDON PHARMA (ELDN)
NASDAQ
$3.44-$0.05 (-1.40%)
Price as of Jun 03, 2026 7:58 PM EDT- $294.1MMarket Cap
- 11.36%1-Year Change
- BiotechnologyIndustry
ELEDON PHARMA (ELDN)
$3.44-$0.05 (-1.40%)
ELDN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.49 | ||
Change | -$0.04 (-1.13%) | ||
Open | $3.50 | ||
High | $3.51 | ||
Low | $3.43 | ||
Previous Close | $3.53 | ||
Volume | 1,062,036 | ||
30-Day Average Volume | 1,095,372 | ||
1-Week Change | -10.51% | ||
1-Month Change | -5.42% | ||
1-Year Change | 15.18% | ||
3-Year Change | 80.83% | ||
5-Year Change | -61.39% | ||
Fundamentals | |||
Shares Outstanding | 77.2M | ||
Total Assets | $146.7M | ||
Market Cap | $294.1M | ||
Enterprise Value | $287.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$39.0M | ||
Free Cash Flow | -$22.6M | ||
EBIT | -$39.0M | ||
EBITDA | -$39.0M | ||
Net Working Capital | $100.1M | ||
EPS | -$0.33 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -12 | ||
PEG | 0 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 18 | ||
Last Split Date | 10/05/2020 | ||
Earnings & Revenue